Organization · Venture Capital
Sciety
Sciety is a venture capital firm based in Stockholm, Sweden, focused on investing in innovative life science and health tech companies primarily in the Nordic region. The firm emphasizes a long-term, active ownership approach and collaborates with experienced investors to support promising ventures.
Overview
What Sciety does
What Sciety is
Sciety is a venture capital firm based in Stockholm, Sweden, focused on investing in innovative life science and health tech companies primarily in the Nordic region. The firm emphasizes a long-term, active ownership approach and collaborates with experienced investors to support promising ventures.
How it participates in the startup ecosystem
The current public profile supports funder and community and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder · Community · Event host
- Last reviewed
- April 23, 2026
Official channels
Find Sciety elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sciety as a funder
Investment thesis
Sciety is exclusively focused on life science and health tech in the Nordics, emphasizing long-term, active ownership. They invest in private growth companies with strong positions in biologics, precision medicine, diagnostics, and digital health.
Focus narrative
Sciety specializes in investments in unlisted growth companies within the life science and health tech sectors. Their investment strategy emphasizes companies that develop scalable solutions to medical challenges, particularly those with clear clinical needs and strong commercial potential. They operate primarily in the Nordic region and often co-invest with other venture capital firms.
Value beyond capital
Sciety adds value to its portfolio companies through active involvement in their growth journey, leveraging a network of experienced investors and industry experts. They provide access to capital, strategic guidance, and connections within the life science sector to help companies scale effectively.
Terms and economics
- Typical check
- $4,400,000–$17,500,000
Focus and fit
- Stages
- Growth Equity
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include: PeptiSystems: Develops technology for large-scale production of precision drugs. Akiram Therapeutics: Focuses on targeted radioimmunotherapy for cancer treatment. Capitainer: Offers intelligent solutions for self-sampling blood and urine. Neogap Therapeutics: Develops personalized cancer therapies using machine learning algorithms. Predicare: Provides a system used by emergency units for patient assessment. Elypta: Works on early cancer diagnosis through metabolite analysis. Likvor: Develops diagnostic systems for the under-diagnosed disorder NPH. CARTANA: Analyzes tissue samples for drug development processes.
Capability profile
Sciety as a community
Community overview
Sciety is a long-term capital partner in the life science sector, founded in 2016 and based in Stockholm, Sweden. The organization focuses on investing in pioneering life science companies that have the potential to make significant contributions to healthcare. Sciety specializes in investments in unlisted growth companies within the life science and health tech sectors, emphasizing scalable solutions to medical challenges.
Community focus
Sciety operates primarily in the Nordic region, focusing on unlisted growth companies that develop innovative solutions in life sciences and health tech. Their investment strategy targets companies with clear clinical needs and strong commercial potential, particularly in biologics, precision medicine, diagnostics, and digital health.
Member value
Members of the Sciety Venture Partners network gain access to a curated syndicate of experienced investors and opportunities to connect with growth companies in the life science sector. They benefit from insights and updates through newsletters and press releases, as well as networking events and investor presentations.
Membership
- Pricing models
- free
Format and cadence
- Modality
- in-person
- Schedule
- rolling-admissions
- Commitment
- light
Availability
- Membership state
- Accepting
Audience and fit
- Audience
- Investors · Founders
- Benefits
- network-access
- Program types
- community
- Selection criteria
- open
- Stages
- Growth Equity
- Sectors
- Healthcare
- Regions
- Nordics
Community activity
Events and activity
Sciety organizes investor presentations, seminars, and networking events aimed at connecting investors with growth companies in the life science sector. These events facilitate collaboration and investment opportunities within the community.
Notable members
Notable portfolio companies include PeptiSystems, Akiram Therapeutics, Capitainer, Neogap Therapeutics, Predicare, Elypta, Likvor, and CARTANA. The team includes co-founders Andreas Lindblom and Malin Härdig, along with other industry leaders.
Capability profile
Sciety as an event host
Event focus
Sciety specializes in investments in unlisted growth companies within the life science and health tech sectors. Their investment strategy emphasizes companies that develop scalable solutions to medical challenges, particularly those with clear clinical needs and strong commercial potential.
Format narrative
Sciety organizes investor presentations, seminars, and networking events to connect investors with growth companies in the life science sector.
Participant value
Sciety provides access to capital for growth companies in the life science sector, facilitating their development and expansion.
Format and cadence
- Event types
- meetup
- Modality
- in-person
- Startups can present
- Yes
Availability
- Registration state
- Not currently accepting
Audience and fit
- Stages
- Growth Equity
- Audience
- Investors · Founders
- Sectors
- Healthcare
- Regions
- Nordics
Common questions
What to know about Sciety
Upseed classifies Sciety under the Venture Capital organization type. Its current public profile includes funder, community, and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.